STOCK TITAN

Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused on foot and ankle orthopedics, will participate in a fireside chat at the Bank of America Securities 2023 Healthcare Conference on May 10, 2023, at 5:20 p.m. ET. The event will feature Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO. Investors can access a live webcast and the archived recording via the company's investor relations website.

Based in Englewood, Colo., Paragon 28 aims to improve patient lives with innovative orthopedic solutions addressing various foot and ankle conditions. The company's offerings focus on enhancing surgical outcomes and reducing complication rates, reflecting their commitment to patient and surgeon needs.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will participate in a fireside chat at the Bank of America Securities 2023 Healthcare Conference on Wednesday, May 10, 2023, at 5:20 p.m. Eastern Time / 3:20 p.m. Mountain Time.

A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Matt Brinckman

Senior Vice President, Strategy and Investor Relations

(720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

When is Paragon 28's fireside chat at the Bank of America Securities 2023 Healthcare Conference?

Paragon 28's fireside chat is scheduled for May 10, 2023, at 5:20 p.m. Eastern Time.

Who from Paragon 28 will be speaking at the conference?

Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will represent Paragon 28 at the conference.

Where can I watch the Paragon 28 conference webcast?

The live webcast and archived recording will be available on Paragon 28's investor relations website at ir.paragon28.com.

What is the stock symbol for Paragon 28?

The stock symbol for Paragon 28 is FNA.

What does Paragon 28 specialize in?

Paragon 28 specializes in medical devices focusing on the foot and ankle orthopedic market.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

507.10M
83.54M
40.68%
60%
8.17%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD